Nitrobenzene is a carcinogen, which induces—among others—thyroid tumors. Melatonin is an effective antioxidant, whereas some antioxidative effects of propylthiouracil (PTU; an antithyroid medication used for the treatment of thyrotoxicosis) were also found. The aim of the study was to compare protective effects of melatonin and PTU against lipid peroxidation in homogenates of porcine thyroids, incubated in the presence of nitrobenzene.
Methods:
Homogenates of porcine thyroids were incubated for 30 min in the presence of nitrobenzene (0.001, 0.01, 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 mM). The level of lipid peroxidation products (malondialdehyde + 4-hydroxyalkenals) was measured spectrophotometrically. Nitrobenzene (7.5 and 10.0 mM) increased lipid peroxidation in the homogenates of porcine thyroids. Subsequently, homogenates of porcine thyroids were incubated for 30 min in the presence of nitrobenzene (7.5 mM) plus one of the antioxidants: melatonin (0.000001, 0.00001, 0.0001, 0.001, 0.01, 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, and 7.5 mM) or PTU (0.01, 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, and 7.5 mM).
Results:
Lipid peroxidation caused by nitrobenzene was effectively prevented by melatonin, with the lowest effective concentration of 0.0001 mM, being only two orders of magnitude higher than physiological blood concentration in humans. At the same time, PTU revealed protective effects only in the highest used concentration (7.5 mM), which is practically never reached during pharmacological treatment in patients with thyrotoxicosis.
Conclusions:
Melatonin can serve as an effective agent in protection against nitrobenzene-induced lipid peroxidation in porcine thyroid.
Agency for Toxic Substances and Disease Registry (ATSDR) (1990) U.S. Public Health Service, Toxicological profile for nitrobenzene. pp. 1–20. Available at: http://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=532&tid=95 (accessed on 14 September 2011).
2.
AndersohnFKonzenCGarbeE (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Annals of Internal Medicine146(9): 657–665.
3.
BradfordMM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry72: 248–254.
4.
CattleyRCEverittJIGrossEAMossORHammTEJrPoppJA (1994) Carcinogenicity and toxicity of inhaled nitrobenzene in B6C3F1 mice and F344 and CD rats. Fundamental and Applied Toxicology22(3): 328–340.
5.
ChastainMARussoGGBohEEChastainJBFalabellaAMillikanLE (1999) Propylthiouracil hypersensitivity: report of two patients with vasculitis and review of the literature. Journal of the American Academy of Dermatology41(5 Pt 1): 757–764.
6.
El-SokkaryGHReiterRJTanDXKimSJCabreraJ (1999) Inhibitory effect of melatonin on products of lipid peroxidation resulting from chronic ethanol administration. Alcohol and Alcoholism34(6): 842–850.
7.
HicksMWongLSDayRO (1992) Antioxidant activity of propylthiouracil. Biochemical Pharmacology43(3): 439–444.
8.
HolderJW (1999) Nitrobenzene potential human cancer risk based on animal studies. Toxicology and Industrial Health15(5): 458–463.
9.
HolderSMJoyMSFalkRJ (2002) Cutaneous and systemic manifestations of drug-induced vasculitis. The Annals of Pharmacotherapy36(1): 130–147.
HsuCHStedefordTOkochi-TakadaEUshijimaTNoguchiHMuro-CachoC. (2007) Framework analysis for the carcinogenic mode of action of nitrobenzene. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis and Ecotoxicology Reviews25(2): 155–184.
12.
IchikiYAkahoshiMYamashitaNMoritaCMaruyamaTHoriuchiT. (1998) Propylthiouracil-induced severe hepatitis: a case report and review of the literature. Journal of Gastroenterology33(5): 747–750.
13.
IkedaMKitaA (1964) Excretion of p-nitrophenol and p-aminophenol in the urine of a patient exposed to nitrobenzene. British Journal of Industrial Medicine21: 210–213.
14.
International Agency for Research on Cancer (IARC) (1996) Printing processes and printing inks, carbon black and some nitro compounds. IARC Monographs Lyon, France, Volume No 65: 25–26. Available at: http://monographs.iarc.fr/ENG/Monographs/vol65/volume65.pdf (accessed on 14 September 2011).
15.
KarbownikMGittoELewinskiAReiterRJ (2001a) Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: melioration by melatonin. Cell Biology and Toxicology17(1): 33–40.
16.
KarbownikMGittoELewinskiAReiterRJ (2001b) Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in hamster testes. Journal of Cellular Biochemistry81(4): 693–699.
17.
KarbownikMLewinskiA (2003) Melatonin reduces Fenton reaction-induced lipid peroxidation in porcine thyroid tissue. Journal of Cellular Biochemistry90(4): 806–811.
18.
KarbownikMReiterRJGarciaJJTanD-XQiWManchesterLC (2000a) Melatonin reduces rat hepatic macromolecular damage due to oxidative stress caused by δ-aminolevulinic acid. Biochimica et Biophysica Acta1523(2–3): 140–146.
19.
KarbownikMStasiakMZasadaKZygmuntALewinskiA (2005) Comparison of potential protective effects of melatonin, indole-3-propionic acid, and propylthiouracil against lipid peroxidation caused by potassium bromate in the thyroid gland. Journal of Cellular Biochemistry95(1): 131–138.
20.
KarbownikMStasiakMZygmuntAZasadaKLewinskiA (2006) Protective effects of melatonin and indole-3-propionic acid against lipid peroxidation, caused by potassium bromate in the rat kidney. Cell Biochemistry and Function24(6): 483–489.
21.
KarbownikMTanDManchesterLCReiterRJ (2000b) Renal toxicity of the carcinogen delta-aminolevulinic acid: antioxidant effects of melatonin. Cancer Letters161(1): 1–7.
22.
KarbownikMTanDXReiterRJ (2000c) Melatonin reduces the oxidation of nuclear DNA and membrane lipids induced by the carcinogen delta-aminolevulinic acid. International Journal of Cancer88(1): 7–11.
23.
KonturekSJKonturekPCBrzozowskiTBubenikGA (2007) Role of melatonin in upper gastrointestinal tract. Journal of Physiology and Pharmacology58(Suppl 6): 23–52.
24.
MarnettLJ (1999) Lipid peroxidation-DNA damage by malondialdehyde. Mutation Research424(1–2): 83–95.
25.
Murawska-CialowiczEJethonZMagdalanJJanuszewskaLPodhorska-OkolowMZawadzkiM. (2011) Effects of melatonin on lipid peroxidation and antioxidative enzyme activities in the liver, kidneys and brain of rats administered with benzo(α)pyrene. Experimental and Toxicologic Pathology63(1–2): 97–103.
26.
Oner-IyidoğanYGürdölFOnerP (2001) The effects of acute melatonin and ethanol treatment on antioxidant enzyme activities in rat testes. Pharmacological Research44(2): 89–93.
27.
ParanichAVParanichLIVasylenkoNMBuhaĭOVButenkoLVSysaIV. (1994) Effect of nitrobenzene and its chlorine derivatives on antioxidative homeostasis. Fiziolohichnyĭ zhurnal40(2): 82–87.
28.
QiWReiterRJTanDXManchesterLCKimSJGarciaJJ (1999) Inhibitory effects of melatonin on ferric nitrilotriacetate-induced lipid peroxidation and oxidative DNA damage in the rat kidney. Toxicology139(1–2): 81–91.
29.
SevenRGelişgenRSevenAErbilYBozboraABurçakG (2001) Influence of propylthiouracil treatment on oxidative stress and nitric oxide in Basedow disease patients. Journal of Toxicology and Environmental Health Part A62(7): 495–503.
30.
StasiakMZasadaKLewinskiAKarbownik-LewinskaM (2010) Melatonin restores the basal level of lipid peroxidation in rat tissues exposed to potassium bromate in vitro. Neuro Endocrinology Letters31(3): 363–369.
31.
SusaNUenoSFurukawaYUedaJSugiyamaM (1997) Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicology and Applied Pharmacology144(2): 377–384.
32.
TouitouYFèvreMBogdanAReinbergADe PrinsJBeckH. (1984) Patterns of plasma melatonin with aging and mental condition: stability of nyctohemeral rhythms and differences in seasonal variations. Acta Endocrinologica106(2): 145–151.
33.
UtasSKoseKYaziciCAkdasAKelestimurF (2002) Antioxidant potential of propylthiouracil in patients with psoriasis. Clinical Biochemistry35(3): 241–246.
